Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

View source ↗

Summary

This Clinical Trial Update documents the establishment and standardization of a platform for in-depth tumor profiling (TUPRO-Gyn) in patients with advanced and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Adenocarcinoma of Ovary, Adenocarcinoma, Tubular | Status: COMPLETED